Ingredion Incorporated INGR
Composite 59/100; the shares have moved about 19% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Momentum ranks 31/100 — a moderate mark against it.
Balance-sheet strength ranks 80/100 — a strong point in its favour. Valuation ranks 75/100 — a strong point in its favour. Income ranks 74/100 — a moderate point in its favour.
Momentum ranks 31/100 — a moderate mark against it. Growth ranks 37/100 — a moderate mark against it.
What the company does Ingredion manufactures sweeteners, starches, nutrition ingredients, and biomaterials from corn and other starch-based materials for food, industrial, and biomaterial applications across global markets.
Key financials ROE 16.2%, ROA 7.9%, ROCE 14.1%; gross/operating/net margins 24.5%/11.9%/9.4%; revenue growth -1.2%, EPS growth -26.0%; debt/equity 0.41, net debt/EBITDA 0.76, interest coverage 25.43, current ratio 2.76.
Stock health Overall Sideravia score 56.3 (average quality, attractively valued, weak momentum); quality 53.5, growth 15.2, strength 84.2, valuation 79.2, momentum 24.3, income 86.7. Piotroski F-Score 6/9, Altman Z 3.75.
Price vs fair value The stock trades at a discount versus both our fair-value estimate and the analyst target. - Price is trading at a discount of 61.10% versus our fair-value estimate of 161.63. - Price is trading at a discount of 20.77% versus the analyst 12-month target of 121.17. - Analysts estimate INGR to report a decline in earnings (Zacks, 2026-07-28) - Kraft Heinz expected to beat earnings estimates (Zacks, 2026-07-29) - Bunge Global lifted its outlook (Trefis, 2026-07-30)
Looking forward Forward P/E 9.31, PEG 2.10, EV/EBITDA 6.28; dividend yield 3.2%, payout 31.4%. Valuation metrics suggest potential undervaluation relative to fundamentals, though earnings growth remains challenged.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-03, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.